Subcutaneous Recombinant Human Erythropoietin for the Treatment of Anemia in Myelodysplastic Syndromes
- 1 January 1993
- journal article
- research article
- Published by S. Karger AG in Acta Haematologica
- Vol. 90 (2) , 58-64
- https://doi.org/10.1159/000204377
Abstract
Recombinant human erythropoietin (rhEPO) was administered subcutaneously to 13 anemic (HbKeywords
This publication has 0 references indexed in Scilit: